At its Jan. 7 meeting, the Ocean City Planning Board deadlocked 4-4 on the issue of recommending that the Wonderland Pier ...
TARA-002 selected for FDA manufacturing development and readiness pilot programNEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) -- ...
As ESG continues to emerge as a key benchmark for corporate governance capacity and sustainable growth, CMC Telecom has been ...
This is read by an automated voice. Please report any issues or inconsistencies here. Trump administration proposes excluding nursing and other fields from “professional” designation, capping graduate ...
Section 1. Purpose. This order sets in motion a process by which certain chapters or other subdivisions of the Muslim Brotherhood shall be considered for designation as Foreign Terrorist Organizations ...
The seven targeted attacks on “go fast” boats allegedly carrying illicit drugs in the Caribbean awakened discussions in the policy and legal communities on the legality of the strikes. While the ...
Cell and gene therapy experts question where the FDA designation fits in an environment that features a range of intersecting regulatory perks. The FDA’s recently created advanced manufacturing ...
The agency said it also plans to develop a new rule for future hazardous substance designations under CERCLA, saying it would be a “statutory fix to protect passive receivers from liability.” News ...
Warsaw, Indiana – 17 September 2025: Jonathan Tueting, MD of Rush Orthopaedics & Sports Medicine in Aurora, Illinois performed the very first carpometacarpal (CMC) total joint arthroplasty in the ...
OPELIKA — Russell Jones, MMC (Master Municipal Clerk)/CMC (Certified Municipal Clerk), City Clerk for the City of Opelika, recently completed his designation as a Certified Elections/Registration ...
Experienced insurance brokers know that in today’s highly competitive and constantly evolving business environment, it’s no longer enough to be a licensed broker. While it is entirely possible to run ...
The FDA awarded Regenerative Medicine Advanced Therapy (RMAT) designation to GNSC-001, a potential gene therapy from Genascence that blocks interleukin 1 (IL-1) for the treatment of knee ...